Institutes of Biomedical Sciences, Shanxi University (IBMS) began preparations for the establishment in March 2015, formally founded in May 2017, which is the first biomedical research institute in the Mid-West Region, and the fourth of China. It is actively founded by Shanxi University as a key construction of the discipline and research institute in response of the 13^th Five-Year Plan for Precision Medical Development of China, relying on the “National Key Construction of One Province, One University in Mid-West China”. After more than a year of active preparation and construction, IBMS has completed the laboratory infrastructure and construction of 2500 m² laboratory system, including molecular laboratory, cell laboratory, zebrafish model centers, especially two high levels of P2 ⁺ laboratories; finished the first batch of 20 million yuan worth of experimental instruments and equipment procurement projects; introduced a total of 14 high level research scientists with overseas research experience, achieving expected goals in terms of hardware construction and talent construction.

     There are four research centers and three high level experiment platform in IBMS, including human serious infectious diseases and anthropozoonosis research center, Mid-West high-incidence cancer research center, human rare genetic diseases research and application center, stem cell technology and application center; molecular biology, cell biology and experimental animal platform. Based on these research centers and platform, IBMS focuses research on: human TB pathological mechanism and molecular mechanism of susceptibility, HIV/AIDS and hepatitis C infection mechanism research, colorectal tumour biology, natural anticancer drug research, association between environmental toxicology and tumorigenesis, human rare genetic diseases research, hedgehog signaling pathways and its relationship with metabolic disease development, embryonic stem cell research.

     IBMS aims to answer major scientific questions and achieve important technical innovation; carry out basic, applied basic and applied research combined with the clinical demand by applying means of modern biology and related interdisciplinary, discover new mechanism, put forward new ideas, develop new drugs, create a new plan; promote the integration of production-study-research, pay attention to the technology and drug innovation of major disease prevention, diagnosis and treatment.

     IBMS is ever a major reform of Shanxi University. It has reached the leading level in the Mid-West Region, with advanced hardware, proficient and competent research team, first-class management operation, and excellent international reputation. IBMS is making every effort to overcome difficulties and improve itself in hopes of becoming the leader of basic and applied research center across Mid-West Region, and even China in the next 5 to 10 years of construction and development.